The U.S. economy finds itself at a crossroads, with leading financial institutions and economic forecasters presenting a varied, yet generally cautious, outlook on the probability of a recession. From machine learning algorithms to traditional yield curve models, the consensus is that while a severe downturn isn't a foregone conclusion,
The U.S. economy finds itself at a critical juncture, as signals from The Conference Board's Leading Economic Index (LEI) point toward a sustained period of economic weakening. While the LEI's consistent downward trend has historically preceded recessions, The Conference Board maintains a nuanced outlook, forecasting a "significant slowdown" rather
The U.S. labor market experienced a significant and unexpected softening throughout 2024 and early 2025, with recent benchmark revisions revealing that nearly a million fewer jobs were created than initially estimated. This dramatic recalibration of employment figures has sent ripples through financial markets and prompted a reassessment of the
The U.S. labor market is undergoing a significant transformation, marking a definitive end to the candidate-driven hiring frenzy that characterized the post-pandemic recovery. For the first time in over four years, the number of job openings has fallen below the total count of unemployed individuals. This critical shift, observed
In a stark reversal from the "Great Resignation" era, a new trend is sweeping across the global labor market: "job hugging." This phenomenon sees employees clinging to their current positions, often out of financial necessity and a deep-seated risk aversion in an increasingly uncertain economic climate. With inflation persistent, interest
The United States economy finds itself in a peculiar and increasingly divergent state, often dubbed a "two-speed economy" when it comes to consumer financial health. While headline economic indicators continue to paint a picture of resilience, driven by robust employment and overall consumer spending, a closer look beneath the surface
The latest U.S. employment report for August 2025 has sent a palpable chill through financial markets and economic forecasts, confirming a significant deceleration in the nation's labor market. Following a rare job contraction in June—the first monthly decline in nonfarm jobs since December 2020—the unemployment rate has
The United States economy is currently navigating a treacherous path, caught between an aggressive trade policy involving widespread tariffs and the looming specter of stagflation. A significant escalation in U.S. tariff rates, reaching levels not seen in over a century, is creating a complex interplay of rising consumer prices,
With growing revenue, a clear path to profitability, and a new focus on powering data centers, FuelCell Energy is building a compelling case for a breakout.
Ocean Power Technologies (OPTT) reported a Q1 FY26 revenue miss but beat EPS estimates. The key highlight is a massive 184% surge in its order backlog, signaling a strong future growth outlook.
Champions Oncology posts record Q1 FY26 revenue of $14.0M but reports a wider-than-expected loss due to increased strategic investments in its data platform.
Ocugen shares are trading higher Monday after the company announced a licensing agreement with Kwangdong Pharmaceutical for the exclusive Korean rights to OCU400.
Shares of e-commerce pet food and supplies retailer Chewy (NYSE:CHWY) jumped 5.9% in the afternoon session after Piper Sandler reiterated its "Overweight" rating and $48.00 price target on the company.
Shares of data storage manufacturer Seagate (NASDAQ:STX)
jumped 7.2% in the afternoon session after Bank of America reaffirmed its 'Buy' rating and significantly raised its price target on the stock to $215 from $170.
Arcade company Dave & Buster’s (NASDAQ:PLAY) fell short of the market’s revenue expectations in Q2 CY2025, with sales flat year on year at $557.4 million. Its non-GAAP profit of $0.40 per share was 56.6% below analysts’ consensus estimates.
Shares of advanced nuclear technology company Oklo hit a new all-time high. The milestone continues a remarkable upward trend for the stock, which has climbed over 1,300% in the past year.
Novo Nordisk shares are trading higher Monday after the company announced European Union approval for oral semaglutide to reduce cardiovascular death, heart attack and stroke.
